Hopitaux Iris Sud

Brussels 1000

0 studies enrolling now · 2 studies all time

What they study most

Coagulopathy, HIV Infections, Severe Sepsis

Studies at this site

• Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy — Completed
• Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection — Stopped early